Table 3.
Diary recordings of ON and OFF durations in patients with PD at baseline and after 12 weeks of intervention.
Hours/per day | Baseline (V0) | Range | Post-12 weeks (V1) | Range | p | Change (V1-V0) | ES |
---|---|---|---|---|---|---|---|
OFF period | 6.52 ± 1.66 (6.33) | 3.8–11 | 5.72 ± 2.64 (5.67) | 0–10.33 | 0.04 | −0.80 ± 1.85 | 0.43 |
Moderate | 1.08 ± 1.71 (0) | 0–5.33 | 0.86 ± 1.50 (0) | 0–4.83 | 0.754 | −0.22 ± 1.29 | 0.17 |
Mild | 5.43 ± 2.39 (5.33) | 0.17–11 | 4.86 ± 2.80 (5.67) | 0–10.33 | 0.09 | −0.57 ± 1.47 | 0.39 |
ON period | 9.92 ± 1.76 (10.33) | 5.17–12.5 | 10.76 ± 2.29 (11) | 4.67–15.5 | 0.031 | 0.84 ± 1.86 | −0.45 |
Sleep | 7.56 ± 1.73 (7.83) | 4.67–10.83 | 7.51 ± 1.68 (7.17) | 4.17–10.70 | 0.552 | −0.04 ± 0.78 | 0.05 |
Change in negative value indicates improvement: off period; change in positive value indicates improvement: on period.
Mean ± SD (Medium); p: Wilcoxon signed rank test, α = 0.05, 2-tailed; ES: 0.2 small effect, 0.5 medium effect, 0.8 large effect.
ES, effect size.